MacroGenics Statistics

Total Valuation

MacroGenics has a market cap or net worth of $82.65 million. The enterprise value is -$34.03 million.

Market Cap	82.65M
Enterprise Value	-34.03M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, after market close.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

MacroGenics has 63.09 million shares outstanding. The number of shares has increased by 1.19% in one year.

Current Share Class	63.09M
Shares Outstanding	63.09M
Shares Change (YoY)	+1.19%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	3.09%
Owned by Institutions (%)	54.84%
Float	51.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.53
Forward PS	1.84
PB Ratio	1.04
P/TBV Ratio	1.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.47.

Current Ratio	3.28
Quick Ratio	2.97
Debt / Equity	0.47
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,362.36

Financial Efficiency

Return on equity (ROE) is -60.25% and return on invested capital (ROIC) is -48.42%.

Return on Equity (ROE)	-60.25%
Return on Assets (ROA)	-26.29%
Return on Invested Capital (ROIC)	-48.42%
Return on Capital Employed (ROCE)	-58.80%
Revenue Per Employee	$451,760
Profits Per Employee	-$163,672
Employee Count	341
Asset Turnover	0.65
Inventory Turnover	36.17

Taxes

In the past 12 months, MacroGenics has paid $944,000 in taxes.

Income Tax	944,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.20% in the last 52 weeks. The beta is 1.63, so MacroGenics's price volatility has been higher than the market average.

Beta (5Y)	1.63
52-Week Price Change	-68.20%
50-Day Moving Average	1.51
200-Day Moving Average	2.68
Relative Strength Index (RSI)	39.93
Average Volume (20 Days)	2,035,811

Short Selling Information

The latest short interest is 6.12 million, so 9.70% of the outstanding shares have been sold short.

Short Interest	6.12M
Short Previous Month	6.09M
Short % of Shares Out	9.70%
Short % of Float	11.85%
Short Ratio (days to cover)	15.11

Income Statement

In the last 12 months, MacroGenics had revenue of $154.05 million and -$55.81 million in losses. Loss per share was -$0.89.

Revenue	154.05M
Gross Profit	-38.98M
Operating Income	-99.45M
Pretax Income	-136.37M
Net Income	-55.81M
EBITDA	-91.98M
EBIT	-99.45M
Loss Per Share	-$0.89

Full Income Statement

Balance Sheet

The company has $154.14 million in cash and $37.47 million in debt, giving a net cash position of $116.68 million or $1.85 per share.

Cash & Cash Equivalents	154.14M
Total Debt	37.47M
Net Cash	116.68M
Net Cash Per Share	$1.85
Equity (Book Value)	79.12M
Book Value Per Share	1.25
Working Capital	126.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$69.62 million and capital expenditures -$2.78 million, giving a free cash flow of -$72.40 million.

Operating Cash Flow	-69.62M
Capital Expenditures	-2.78M
Free Cash Flow	-72.40M
FCF Per Share	-$1.15

Full Cash Flow Statement

Margins

Gross margin is -25.30%, with operating and profit margins of -64.56% and -36.23%.

Gross Margin	-25.30%
Operating Margin	-64.56%
Pretax Margin	-35.62%
Profit Margin	-36.23%
EBITDA Margin	-59.71%
EBIT Margin	-64.56%
FCF Margin	n/a

Dividends & Yields

MacroGenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.19%
Shareholder Yield	-1.19%
Earnings Yield	-67.53%
FCF Yield	-87.60%

Analyst Forecast

The average price target for MacroGenics is $5.33, which is 305.32% higher than the current price. The consensus rating is "Hold".

Price Target	$5.33
Price Target Difference	305.32%
Analyst Consensus	Hold
Analyst Count	9
Revenue Growth Forecast (5Y)	-0.60%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MacroGenics has an Altman Z-Score of -6.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.36
Piotroski F-Score	2